Apollo Therapeutics
Growth · Website
- Name
- Apollo Therapeutics
- According to Albion: Apollo Therapeutics
- Stage
- Growth
- According to Albion: Growth
- Website
- https://apollotherapeutics.com/
- Sectors
- Frontiers Strategy
- According to Albion: Frontiers Strategy
View sources
View sources
View sources
No timeline events.
| Name | Title | Location | |
|---|---|---|---|
| Arjun Krishnan | Chief Business Officer | ||
| Becki Maki | VP, Head of Quality and Compliance | ||
| Behnaz Ravanfar | Senior Clinical Project Manager | ||
| Carol Gallagher DPharm | R&D Advisory Committee Member | ||
| Charlotte Lane PhD | Head of Project Management | ||
| Charlotte Wilson | Financial Accountant | ||
| Clara Stead | Principal Scientist | ||
| Clare Burles | VP, People and Communications | ||
| Constantine Chinoporos | Special Advisor | ||
| Daniel Wilkinson PhD | Head of Portfolio and Program Strategy | ||
| Darren Cawkill PhD | VP, Program Leader | ||
| Dipender Gill PhD | Special Advisor | ||
| Don Drakeman PhD | Special Advisor | ||
| Donata Gelzinyte | Assistant Accountant | ||
| Emily Howard | US Office Manager | ||
| Emmanuel Demont PhD | Head of Medicinal Chemistry & DMPK | ||
| Gary Collins | VP, Finance | ||
| Gemma Bishop | FP&A Business Partner | ||
| Greg Roberts PhD | VP, Global Program Leader | ||
| Husseini K. Manji, MD, FRCPC | Special Advisor | ||
| Ian Nicoll | Director, Financial Reporting | ||
| Jamie Heath | Chief Financial Officer | ||
| Jeremy Cooper | Head of IT | ||
| Jessica Jones PhD | Director, Program Leader | ||
| Jim Momtazee | Board Director | ||
| Joana de Abreu Carvalho PhD | VP, Program Leader | ||
| Joe Miletich MD PhD | R&D Advisory Committee Member | ||
| Jordyn Hanover | Senior Clinical Project Manager | ||
| Joshua Black | Senior Director, Clinical Operations | ||
| Juan Hermoso Dianez | FP&A Business Partner | ||
| Kay Penicud PhD | VP, Head of Research Partnerships | ||
| Krishna Kolluri PhD | Principal Scientist | ||
| Laura Furmanski PhD | Board Director | ||
| Laurie Green | Director, Clinical Operations | ||
| Louise Horne | People Business Partner | ||
| Malcolm Begg PhD | VP, Global Program Leader | ||
| Martin Michel PhD | Associate Director, Program & Portfolio Strategy | ||
| Matthew Cardinal | Senior Clinical Scientist | ||
| Megan Carney | Clinical Research Associate | ||
| Megan Murdoch | Business Development Lead | ||
| Mel Glossop | VP, Program Leader | ||
| Michael Owen PhD | R&D Advisory Committee Member | ||
| Michael Weinreich MD PhD | VP, Head of Immunology & Inflammation Clinical Development | ||
| Nadine Clemo PhD | VP, Program Leader | ||
| Nathan Hubbard | Director, FP&A | ||
| Neel Varshney MD | Board Director | ||
| Neil Flanagan | VP, Head of CMC | ||
| Nicole Cipriano | Senior Clinical Project Manager | ||
| Paolo Paoletti MD | R&D Advisory Committee Member | ||
| Peter Parker PhD | R&D Advisory Committee Member | ||
| Priti Patel | Clinical Supply Chain Manager | ||
| Rachel Gurrell PhD | VP, Global Program Leader | ||
| Richard Brown PhD | VP, Global Program Leader | ||
| Richard Butt PhD | Chief Scientific Officer | ||
| Richard Mason MD | Chief Executive Officer | ||
| Rick Dixon | Project Accountant | ||
| Robert Shine | Director, Development Project Manager | ||
| Sam Williams PhD | Board Director | ||
| Samata Pandey PhD | Principal Scientist | ||
| Samuel Brookes | Chemistry Project Manager | ||
| Sanjay Aggarwal MD | Chief Medical Officer | ||
| Shailise Ross PhD | Associate Director, Regulatory Strategy | ||
| Shane Ziemba | In-house Clinical Research Associate | ||
| Stephanie Hopley PhD | VP, Program Leader | ||
| Stephen Shaw PhD | VP, Program Leader | ||
| Sue Barraclough | Executive Assistant | ||
| Sunil Kadam PhD | Chief Regulatory Officer | ||
| Susanne Wright | Director, Chemistry and Research Operations | ||
| Vashine Kamesan | Clinical Project Manager | ||
| Vasundhara Bhargava | Board Director |